Dr. Howard Bergman MD, FCFP, FRCPC, FCAHS is the Assistant Dean, International Affairs, Faculty of Medicine, McGill University where he provides strategic oversight of the international and business development activities in the Faculty of Medicine.
 |
Dr Howard Bergman has made a profound transformative impact on the training and career development of students and faculty in the field of neurocognitive disorders in Quebec, Canada and internationally. He created the Canadian team for healthcare services/system improvement in dementia care, a team dedicated to improving the capacity of primary care to diagnose and treat older persons with Alzheimer’s disease.. This Canadian team for healthcare services/system improvement in dementia care was awarded a $1.2 million grant by CIHR (CCNA) in 2014 which was renewed in 2019. Dr. Bergman is internationally recognized for his research on integrated care, frailty, and chronic disease with over 185 peer-reviewed publications as well as numerous reports and book chapters. His many other accomplishments include: In 2021, Dr. Bergman was appointed to the 24-member World Dementia Council. In 2019, he was invited by the Singapore Ministry of Health for a 2-week mission as a foreign expert on Family Medicine, Primary and Continuity of Care with a focus on primary care and aging And in 2018, he chaired the Canadian Academy of Health Sciences (CAHS) Panel for the Assessment of Evidence and Best Practices for the development of a Canadian Dementia Strategy. The panel submitted its report in January 2019: entitled “ Improving the Quality of Life and Care of Persons Living with Dementia and their Caregivers”. In 2017, he was named honorary member by the Canadian Medical Association for his contribution to the medical profession. From 2009 to 2011, Dr. Bergman served as Vice-President, Scientific Affairs of the Fonds de la recherche en Santé du Québec (FRSQ), Quebec’s health research funding agency. From 1993-2009, he was Director of the Division of Geriatric Medicine at McGill University and of the Jewish General Hospital. In 2001-2002, he was interim Physician-in-Chief and Chief of the Department of Medicine of the Jewish General Hospital. He is an investigator at Solidage: the McGill University/Université de Montréal Research Group on Frailty and Aging as well as at the Bloomfield Centre for Research on Aging at the Lady Davis Institute, Jewish General Hospital. In 2010, Dr. Bergman was a member of the Canadian Academy of Health Sciences Expert Panel on improving chronic disease outcomes through health system transformation which in 2010 tabled its report: Transforming Care for Canadians with Chronic Health Conditions: Put People First, Expect the Best and Manage for Results. In 2000-2001, Dr. Bergman was a member of the “Clair Commission”, an independent Commission set up by the Quebec government to propose reforms to the health care system. His work in that Commission was instrumental in the recommendation on primary care reform. Dr. Bergman was co-founder and co-director of the Jewish General Hospital/McGill University Memory Clinic and Research Program. He is a past president of the Consortium of Canadian Centres for Clinical Cognitive Research (1999) and was a member of the Steering Committee of the second (1999) and third (2006) Canadian Consensus Conference on the Diagnosis and Treatment of Dementia. Appointed by the Quebec Minister of Health in 2007, Dr. Bergman tabled in 2009 a proposal for the Quebec Alzheimer Plan (known in Quebec as the Bergman Plan) from prevention to end of life care, including the research agenda. He is working with the Quebec Ministry of Health in the implementation of the plan. He is a past Chair of the Advisory Board of the Institute of Ageing of the Canadian Institutes of Health Research (CIHR), and a past President of the Canadian Geriatrics Society which awarded him the Ronald Cape Distinguished Service Award. Dr. Bergman is a member of the Board of Directors of the Quebec Institut national d’excellence en santé et en services sociaux (INESSS-the equivalent of NICE in England). He was co-Chair of the National Guidance and Implementation Committee of the pan-Canadian public health program on family violence. He was cohonorary president of the Société francophone d’oncogériatrie. He was Chair of the Board of Directors of AllerGen, the Canadian Allergy, Genes and Environment Network (NCE) and a member of the Board of Directors of the Institute for Research on Public Policy (IRPP). |